Fluphenazine decanoate and tardive dyskinesia: A possible association

J. G. Csernansky, K. Grabowski, J. Cervantes, J. Kaplan, J. A. Yesavage

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

The authors examined in the charts of 22 outpatients who had received intramuscular fluphenazine decanoate and oral fluphenazine hydrochloride to assess the incidence of tardive dyskinesia. The severity of tardive dyskinesia was assessed with the Abnormal Involuntary Movement Scale (AIMS). Both the total dose and average daily dose of fluphenazine decanoate correlated significantly with high AIMS scores. There were also significant correlations of AIMS scores with total dose of antiparkinsonian medication and total dose of other neuroleptics. Total dose of antiparkinsonian medication correlated with total dose of fluphenazine decanoate. The authors discuss the clinical and physiological implications of these correlations.

Original languageEnglish (US)
Pages (from-to)1362-1365
Number of pages4
JournalUnknown Journal
Volume138
Issue number10
DOIs
StatePublished - Jan 1 1981

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Fluphenazine decanoate and tardive dyskinesia: A possible association'. Together they form a unique fingerprint.

  • Cite this

    Csernansky, J. G., Grabowski, K., Cervantes, J., Kaplan, J., & Yesavage, J. A. (1981). Fluphenazine decanoate and tardive dyskinesia: A possible association. Unknown Journal, 138(10), 1362-1365. https://doi.org/10.1176/ajp.138.10.1362